首页> 外文期刊>International Orthopaedics >Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes
【24h】

Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes

机译:经皮注射骨髓间充质干细胞治疗踝关节不愈合可减少糖尿病患者的并发症

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Clinical studies in diabetic patients have demonstrated that there is a high incidence of complications in distal tibia and ankle fracture treatments. One strategy to mitigate issues with wound healing and infection in diabetic patients is to use a percutaneous technique in which autologous, bone marrow-derived, concentrated cells are injected at the site of non-unions.
机译:目的对糖尿病患者的临床研究表明,胫骨远端和踝关节骨折治疗的并发症发生率很高。减轻糖尿病患者伤口愈合和感染问题的一种策略是使用经皮技术,其中将自体,骨髓来源的浓缩细胞注射到不愈合的部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号